Sanigad Hydro Limited (SGHL)
Hydropower · Rs. 537.60 19.40 (+3.74%) as of Aug 17, 2026
Price — last 6 months
Full chart →Open
518.20
High / Low
544.00 / 515.30
Prev. close
518.20
Volume
1.61 L
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—
MASTER score
Mechanical 0–100 technical ranking. Methodology →
Promoter holding—
Public holding—
Stock performance
1-week change
+1.86%
1-month change
+11.77%
3-month change
—
6-month change
—
YTD change
—
1-year change
—
1-month high
587.00
1-month low
468.00
From 52-week high
—
From 52-week low
—
180-day avg price
500.04
360-day avg price
500.04
Avg volume (1w)
79,528
Avg volume (1m)
83,308
Avg volume (6m)
75,301
Avg volume (12m)
75,301
Daily volatility (1m)
2.89%
Beta vs NEPSE (1y)
—
Valuation
EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—
P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →
Key indicators vs Hydropower
EPS (Rs.)
N/A
min -18.87avg 5.14max 29.72
—
P/E
N/A
min 23.01avg 264.41max 8,596.67
—
P/B
N/A
min 2.33avg 4.75max 34.67
—
Networth / Share (Rs.)
N/A
min -23.87avg 100.69max 210.33
—
ROE (%)
N/A
min 0.00avg 6.10max 65.79
—
Technical indicators
| RSI (14) | 66.48 | Neutral |
| MACD | — | — |
| EMA 5 | 525.40 | Bullish |
| EMA 20 | 512.65 | Bullish |
| EMA 180 | — | — |
| SMA 50 | — | — |
| SMA 200 | — | — |
Pivot levels (classic)
S3
491.90S2
503.60S1
520.60PP
532.30R1
549.30R2
561.00R3
578.00Key financials — last 8 quarters
worsebetter vs same quarter last yearamounts in Rs · per-share in RsNo filed statements found.
More Hydropower stocks
SGHL — frequently asked questions
What is Sanigad Hydro Limited's share price?
Rs. 537.60 as of Aug 17, 2026, the latest NEPSE trading session (+3.74% on the day).
What dividend did SGHL pay?
No dividend on record for the most recent fiscal year in our data.
Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.